SCHEMBL5665035

SCHEMBL5665035

CC[CH]NNC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL245695 0.72
SCHEMBL5666866 0.72
SCHEMBL7754689 0.67
SCHEMBL4195727 0.67
SCHEMBL1169064 0.65
SCHEMBL4199885 0.63
Propionic Acid SCHEMBL30633878 0.63 FFAR3 (0.53)
Hydrochloric Acid SCHEMBL23478346 0.62
Fluoride SCHEMBL19458344 0.62
Bromide SCHEMBL19458438 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1545572-A4 CONJUGATES ACTIVATED BY CELL SURFACE PROTEASES AND THERAPEUTIC USES THEREOF DENDREON CORP (US) 2006-04-12 EP disclosed
EP-1545572-A2 CONJUGATES ACTIVATED BY CELL SURFACE PROTEASES AND THERAPEUTIC USES THEREOF Dendreon Corporation (US) 2005-06-29 EP disclosed
US-20040001801-A1 Conjugates activated by cell surface proteases and therapeutic uses thereof CORVAS INTERNATIONAL, INC. 2004-01-01 US disclosed
WO-2002095007-A2 CONJUGATES ACTIVATED BY CELL SURFACE PROTEASES AND THERAPEUTIC USES THEREOF DENDREON SAN DIEGO LLC (US) 2002-11-28 WO disclosed